How Long Can a Person Live with Acute Myeloid Leukemia?

After being diagnosed with acute myeloid leukemia (AML), some patients become intensely preoccupied with their life expectancy. So, how long can patients with AML live?

How Long Can Patients with Acute Myeloid Leukemia Live?

AML is classified into eight subtypes (M0–M7) based on morphological and immunophenotypic features. From a genetic perspective, the presence or absence of specific chromosomal abnormalities significantly influences prognosis. For acute promyelocytic leukemia (APL, subtype M3), all-trans retinoic acid (ATRA) combined with arsenic trioxide markedly improves both the complete remission (CR) rate and overall survival (OS). Prior to the introduction of ATRA and arsenic trioxide, M3 was considered one of the most aggressive forms of AML. With current ATRA–arsenic trioxide therapy, the CR rate exceeds 80%, and the 5-year survival rate also reaches over 80%.

For other AML subtypes, survival duration varies by age: older patients generally have shorter survival times—approximately one year. Without treatment, the median overall survival for AML is about three to six months. With standard chemotherapy, the CR rate reaches approximately 60%, and the 3- to 5-year survival rate is around 50%. Furthermore, allogeneic hematopoietic stem cell transplantation (HSCT) significantly improves long-term survival.

Patients with acute granulocytic leukemia (a subtype of AML) should avoid crowded places when going outdoors, maintain strict personal hygiene, and take precautions against infection during chemotherapy. They should also prioritize adequate rest, prevent colds and influenza, and ensure food safety and cleanliness. During remission, no special precautions are required—patients may resume normal daily activities as healthy individuals. We hope this article has been helpful. Wishing you a joyful life and good health!